These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34741868)

  • 1. Phenylalanine and COVID-19: Tracking disease severity markers.
    Luporini RL; Pott-Junior H; Di Medeiros Leal MCB; Castro A; Ferreira AG; Cominetti MR; de Freitas Anibal F
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108313. PubMed ID: 34741868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection.
    Gietl M; Burkert F; Hofer S; Gostner JM; Sonnweber T; Tancevski I; Pizzini A; Sahanic S; Schroll A; Brigo N; Egger A; Bellmann-Weiler R; Löffler-Ragg J; Weiss G; Kurz K
    Sci Rep; 2024 May; 14(1):10388. PubMed ID: 38710760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19.
    Luporini RL; Rodolpho JMA; Kubota LT; Martin ACBM; Cominetti MR; Anibal FF; Pott-Junior H
    Cytokine; 2021 Jul; 143():155507. PubMed ID: 33839002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
    Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
    J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
    Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
    Front Immunol; 2021; 12():646095. PubMed ID: 33815405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
    Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
    Front Immunol; 2021; 12():592727. PubMed ID: 33968010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile and disease severity in patients with COVID-19.
    Ghazavi A; Ganji A; Keshavarzian N; Rabiemajd S; Mosayebi G
    Cytokine; 2021 Jan; 137():155323. PubMed ID: 33045526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
    Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
    BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.
    Cekerevac I; Turnic TN; Draginic N; Andjic M; Zivkovic V; Simovic S; Susa R; Novkovic L; Mijailovic Z; Andjelkovic M; Vukicevic V; Vulovic T; Jakovljevic V
    Oxid Med Cell Longev; 2021; 2021():6615787. PubMed ID: 33854695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
    Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
    BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Association of Infection-related Biomarkers and Inflammatory Cytokines with the Severity of Coronavirus Disease 2019: A Prospective Observational Study.
    Injarapu RK; Tamboli A; Shah L; Phalgune D
    J Assoc Physicians India; 2024 Aug; 72(8):44-47. PubMed ID: 39163062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.